Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

Literature DB >> 14201553

PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

Abstract

Entities: Species

Keywords: BLOOD PRESSURE; BLOOD VOLUME; HEART; HEART RATE; HEMODYNAMICS; HYPERTHYROIDISM; ISOPROTERENOL; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; PLACEBOS; SYMPATHOLYTICS

Mesh：

Substances：

Year: 1964 PMID： 14201553 PMCID： PMC441969 DOI： 10.1172/JCI105045

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

11 in total

1. EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS.

Authors: D C HARRISON; E BRAUNWALD; G GLICK; D T MASON; C A CHIDSEY; J ROSS
Journal: Circulation Date: 1964-01 Impact factor: 29.690

2. The acute hemodynamic effects of alpha-methyldopa in thyrotoxic patients and normal subjects.

Authors: E O THEILEN; W R WILSON; F J TUTUNJI
Journal: Metabolism Date: 1963-07 Impact factor: 8.694

3. Studies on the metabolism of aromatic amines in relation to altered thyroid function in man.

Authors: R J LEVINE; J A OATES; A VENDSALU; A SJOERDSMA
Journal: J Clin Endocrinol Metab Date: 1962-12 Impact factor: 5.958

4. Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).

Authors: A C DORNHORST; B F ROBINSON
Journal: Lancet Date: 1962-08-18 Impact factor: 79.321

5. Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man.

Authors: T E GAFFNEY; E BRAUNWALD; R L KAHLER
Journal: N Engl J Med Date: 1961-07-06 Impact factor: 91.245

6. Mechanisms of cardiac control in exercise.

Authors: R F RUSHMER; O SMITH; D FRANKLIN
Journal: Circ Res Date: 1959-07 Impact factor: 17.367

7. The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormones.

Authors: W R BREWSTER; J P ISAACS; P F OSGOOD; T L KING
Journal: Circulation Date: 1956-01 Impact factor: 29.690

8. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

Authors: J J CANARY; M SCHAAF; B J DUFFY; L H KYLE
Journal: N Engl J Med Date: 1957-09-05 Impact factor: 91.245

9. THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE.

Authors: R L Kahler; T E Gaffney; E Braunwald
Journal: J Clin Invest Date: 1962-11 Impact factor: 14.808

10. Studies of thyroid and sympathetic nervous system interrelationships. II. Effects of guanethidine on manifestations of hyperthyroidism.

Authors: W Y LEE; D BRONSKY; S S WALDSTEIN
Journal: J Clin Endocrinol Metab Date: 1962-09 Impact factor: 5.958

16 in total

1. W E Dixon Memorial Lecture. Beta-adrenoceptor blockade in hyperthyroidism and anxiety.

Authors: P Turner
Journal: Proc R Soc Med Date: 1976-05

2. Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.

Authors: H Ikram
Journal: Br Med J Date: 1977-06-11

3. Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.

Authors: W R Wilson; E O Theilen; J H Hege; M R Valenca
Journal: J Clin Invest Date: 1966-07 Impact factor: 14.808

PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM.

1. EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS.

2. The acute hemodynamic effects of alpha-methyldopa in thyrotoxic patients and normal subjects.

3. Studies on the metabolism of aromatic amines in relation to altered thyroid function in man.

4. Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide).

5. Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man.

6. Mechanisms of cardiac control in exercise.

7. The hemodynamic and metabolic interrelationships in the activity of epinephrine, norepinephrine and the thyroid hormones.

8. Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

9. THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE.

10. Studies of thyroid and sympathetic nervous system interrelationships. II. Effects of guanethidine on manifestations of hyperthyroidism.

1. W E Dixon Memorial Lecture. Beta-adrenoceptor blockade in hyperthyroidism and anxiety.

2. Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.

3. Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism.

4. Treatment of thyrotoxicosis.

Review 5. Beta-adrenergic receptor blocking drugs in hyperthyroidism.

6. [Effects of thyroid hormones on the heart: electrophysiological effects on the papillary muscle].

7. The relationship between intrinsic heart rate and thyroid status in man.

8. Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.

Review 9. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

10. Influence of the thyroid state on left ventricular tension-velocity relations in the intact, sedated dog.